Ep 76: KEYNOTE 054 7-year follow-up
Melanoma Matters

Ep 76: KEYNOTE 054 7-year follow-up

2025年12月28日28分钟

Summary In this Episode, hosts James & Sapna go into the 7-year follow-up from the randomized phase 3 adjuvant trial of pembrolizumab versus placebo for stage III melanoma, KEYNOTE-054 There's a bit too much talk about weightlifting though...

播放本集

这一集暂时还没有文字稿

你仍然可以在播放器中收听。有文字稿的节目,点任意单词就能看到释义。